Trial · NCT04345718
EXHIT ENTRE Comparative Effectiveness Trial
NCT04345718, Phase 2, Phase 3, Completed, Gavin Bart
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. EXHIT ENTRE Comparative Effectiveness Trial. Trials, record NCT04345718. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04345718
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- EXHIT ENTRE Comparative Effectiveness Trial
- NCT number
- NCT04345718
- Status
- Completed
- Phases
- Phase 2, Phase 3
- Enrollment
- 344 participants, actual
- Lead sponsor
- Gavin Bart
- Conditions
- Substance Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe
- Interventions
- Extended Release Buprenorphine, Treatment as Usual
- First posted
- 2020-04-14
- Last updated
- 2026-11-06
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The proportion of participants engaged in OUD care on the 34th day following hospital discharge. | 34 days post discharge from hospital | Engagement in OUD is defined as coverage with a legitimately prescribed MOUD on that 34th day regardless of the source of prescribed MOUD coverage (e.g., formalized treatment program, primary care, jail, etc.). |
| Secondary | Proportion of participants that experience Adverse Events (AE) | 34 days | 34-days following hospital discharge |
| Secondary | Proportion of participants engaged with MOUD | Days 90 and 180 post hospital discharge | 90- and 180-days following hospital discharge |
| Secondary | Proportion of participants with positive urine drug test | Days 34, 90 and 180 post hospital discharge | for illicit opioids 34-, and 90-, and 180-days following hospital discharge |
| Secondary | Proportion of participants with self-reported opioid use | Days 34, 90 and 180 post hospital discharge | |
| Secondary | Self-reported 30- and 90-day hospital readmission rates | Days 30 and 90 post hospital discharge | |
| Secondary | Self-reported 30- and 90-day Emergency Department (ED) visit rates | Days 30 and 90 post hospital discharge |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| UG1DA040316 | NorthStar Node of the NIDA Clinical Trials Network | BART, GAVIN | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | NATIONAL INSTITUTE ON DRUG ABUSE | 2015 to 2025 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04345718
GET https://conductscience.org/api/trials/v1/NCT04345718/registered